Overview
- 3 inspections across 3 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2016-04-01.
At a glance
Inspections
3
Sites
3
Observations
1
Career since
Oct 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Vet Path Services Inc | 1 Apr 2016 | Human Drugs | On file |
| GlaxoSmithKline LLC | 18 Mar 2016 | Human Drugs | View 483 → |
| Battelle Biomedical Research Center | 23 Oct 2015 | Human Drugs |
Sites inspected
Vet Path Services IncMason, United States1 insp.
GlaxoSmithKline LLCKing Of Prussia, United States1 insp.
Battelle Biomedical Research CenterWest Jefferson, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Abhijit Raha2 shared
Tahseen Mirza1 shared
Marcelo O Mangalindan1 shared
Mark J Seaton1 shared
Richard W Berning1 shared
Andria L Kuhlman1 shared
Zhou Chen1 shared
Hugh M Mcclure1 shared
Full investigator report
Get the verbatim findings behind Ching-Jey G Chang's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site